Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sphenopalatine Ganglion Block With Adrenaline Additive for Post-Dural Puncture Headache in Orthopedic Patients: A Randomized Controlled Study

NCT04657952 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT04657952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04657952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sphenopalatine Ganglion Block With Adrenaline Additive for Post-Dural Puncture Headache in Orthopedic Patients: A Randomized Controlled Study
Lead sponsor
Tanta University
Phase
Phase 4
Overall status
Unknown status
Start date
December 10, 2020
Completion date
May 20, 2021
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adrenaline, orthopedic, post-dural puncture headache, randomized controlled study, sphenopalatine ganglion block